Flores Osvaldo 4
4 · Century Therapeutics, Inc. · Filed Jan 27, 2022
Insider Transaction Report
Form 4
Flores Osvaldo
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-25+315,000→ 315,000 totalExercise: $13.15Exp: 2032-01-25→ Common Stock (315,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.